Answer
Sodium valproate/valproic acid passes into breast milk at 1–10% of maternal serum levels; blood disorders have occurred in breastfed newborns/infants, so deciding whether to stop breastfeeding or discontinue/avoid valproate therapy must consider breastfeeding benefits for the child and treatment benefits for the woman.
Sources for this answer
- Epilim Chrono 500mgSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 45Document updated
Sources checked